NKF Names New Chief Scientific Officer
Kerry Willis, PhD, has been promoted to Chief Scientific Officer of the NKF.
Kerry Willis, PhD, has been promoted to Chief Scientific Officer of the National Kidney Foundation (NKF).
“For over 15 years, Kerry has provided exemplary scientific leadership at the NKF,” the foundation's CEO, Bruce Skyer, stated in a press release.“This promotion recognizes her key role in advancing the knowledge and treatment of kidney disease, and reaffirms our goal of working closely with healthcare practitioners to positively impact the lives of kidney patients.”
As Chief Scientific Officer, Dr. Willis will work to ensure that NKF guidelines and clinical practices are applied by healthcare practitioners across the nation.
“I am excited about the progress we have made so far, and look forward to continuing my work with the NKF,” she said. “It is a privilege to have the opportunity to positively change the lives of millions of Americans living with kidney disease.”
Dr. Willis has been with the NKF since 1998, previously working as the Senior Vice President for Health Science and Education where she founded NKF's Medical Activities division and spearheaded many initiatives such as the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines. She received her PhD in Molecular Genetics from New York University Medical Center.